Drgem Corp (263690) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Drgem Corp (263690:KRX), powered by AI.

Current Price
₩5,350
P/E Ratio
8.9
Market Cap
60.6B
Sector
Healthcare
What is the Drgem Corp stock price forecast?

Drgem Corp is currently trading at ₩5,350. View real-time AI analysis on Alpha Lenz.

What is Drgem Corp insider trading activity?

View the latest insider trading data for Drgem Corp on Alpha Lenz.

What is Drgem Corp's P/E ratio?

Drgem Corp's P/E ratio is 8.9.

Drgem Corp

KRX · 263690
₩5,350+80(+1.52%)Market closedKRX regular session 09:00–15:30 KST
Ask about Drgem Corp's future dividend policy...
Alpha Chat Insight

Drgem Corp trades at a P/E of 8.9 (undervalued) with modest ROE of 7.6%.

Ask for details

Company Overview

Drgem Corp is an established player in the industrial technology sector, specializing primarily in the manufacturing and distribution of medical imaging equipment. The company's primary focus lies in the development of X-ray systems, which are essential for diagnostic procedures in the healthcare industry. Drgem Corp's product portfolio is not only vital for hospitals and clinics but also finds applications across diverse medical fields, enhancing diagnostic efficiency and patient care. Drgem Corp operates with a commitment to innovation and quality, integrating advanced technology solutions to improve the performance and reliability of its imaging systems. The company's contributions are significant within the healthcare sector, where the demand for accurate, non-invasive diagnostic tools continues to grow. Drgem Corp supports a broad clientele, supplying both high-end and more accessible X-ray solutions adapted to various clinical needs. In the financial markets, Drgem Corp's role underscores its influence in the healthcare industry, benefiting from trends towards digital health solutions and increasing investments in medical infrastructure. This positions the company not only as a key contributor to healthcare advancements but also as a vital component for investors looking to engage with the medical technology sector.

CEO박정병
SectorHealthcare
IndustryMedical Devices
Employees267

Company Statistics

FY 2025

Profile

₩60,592,013,500Market Cap
₩102,746,224,630Revenue
11.33MShares Out
267Employees

Margins

31.35%Gross
11.11%EBITDA
8.78%Operating
6.64%Pre-Tax
6.60%Net

Valuation

8.94P/E
0.66P/B
0.59EV/Sales
5.05EV/EBITDA
8.40P/FCF

Growth (CAGR)

-2.30%Rev 3Yr
-0.73%Rev 5Yr
-18.96%Op Inc 3Yr
-17.06%Op Inc 5Yr
-22.19%Net Inc 3Yr
-19.45%Net Inc 5Yr

Returns

5.56%ROA
7.58%ROE
5.96%ROIC

Financial Health

₩13,645,897,390Cash & Cash Equivalents
₩16,207,538,200Net Debt
32.41%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Drgem Corp (ticker: 263690) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 267 employees. Market cap is $60.6B.

The current price is ₩5,350 with a P/E ratio of 8.94x and P/B of 0.66x.

ROE is 7.58% and operating margin is 8.78%. Annual revenue is $102.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Drgem Corp (263690) Stock Forecast 2026 ₩5,350 — Price, Financials & Analyst Targets | Alpha Lenz